1.4600.00% ( 0.000 )
Delay Closed: Nov 13, 16:08:17Valuation
Current ValuationThe current P/E ratio is -1.53, above the reasonable range, cheaper than 10.38% of the time in the past 1 years, and the industry ranks 8/12, the industry Median 8.88.
-1.53xP/E
HK$1.46Stock price
HK$-0.96Earnings per share
-1.53xP/E
Stock priceHK$1.46Earnings per shareHK$-0.96
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -10.48x
- Typical range
- -15.02x–-1.92x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 8.88x
07142128
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 8.88x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
02170HKBASECARE-B | -1.87x | 27.39% | HK$373.94M |
08622HKJOYZYME GROUP | -26.95x | -- | HK$154.64M |
00876HKQH BIO PHARMA | -1.53x | -- | HK$151.30M |
02393HKYESTAR HEALTH | -1.21x | -- | HK$116.58M |
01134HKKELFRED | -4.59x | -- | HK$102.50M |
08513HKMAXWIN INT HLDG | -10.65x | -- | HK$26.19M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
